Ketamine

Questions discussed in this category

How do you determine the treatment course of esketamine or IV ketamine when used for treatment-resistant major depressive disorder?

1 Answer available

Papers discussed in this category

Biological psychiatry, 2010-01-15

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

Molecular psychiatry, 2018-10-03

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).

Journal of affective disorders, 2020 Jul 21

The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis.

The Journal of clinical psychiatry, 2023 Feb 01

Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study.

CNS drugs, 2023 Aug 09

Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023 May 12

Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study.

Related Topics